Matthew William Arnold, MD
Neurology · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 25 years
- University of California, Davis School of Medicine, 2001
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 057004 · Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Arnold’s office at (510) 204-8140 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A81482 · Current
Licensed to practise in California · since 2002 · expires 2028-06-30 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Neurology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$427,284
Medicare paid this office $427,284 for 940 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Botox | 82 | $210,248 | None |
| Short return visit (20+ min) | 399 | $45,560 | $75 |
| Return visit (30+ min) | 223 | $32,877 | $110 |
| New patient visit (60+ min) | 105 | $19,177 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 147 | $16,827 | $69 |
See all 18 services
| Botox | 82 | $210,248 | None |
| Short return visit (20+ min) | 399 | $45,560 | $75 |
| Return visit (30+ min) | 223 | $32,877 | $110 |
| New patient visit (60+ min) | 105 | $19,177 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 147 | $16,827 | $69 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 92 | $13,536 | $147 |
| Long return visit (40+ min) | 55 | $9,797 | $158 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 23 | $9,323 | $137 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 21 | $7,871 | $149 |
| Face injection for nerve paralysis | 21 | $7,777 | $144 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 16 | $5,808 | $142 |
| New patient visit (45+ min) | 45 | $5,756 | $128 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,123 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $3,565 | $105 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 57 | $3,485 | $42 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 146 | $3,168 | $15 |
| Short return visit | 39 | $3,131 | $47 |
| Measurement of brain wave activity (eeg), awake and drowsy | 44 | $2,212 | $49 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 49 | 50 | 46 | 45 | 55 | 53 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | – | 35 | 45 | 67 | 80 | 68 |
| Face injection for nerve paralysis | 30 | 27 | 30 | 32 | 41 | 54 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 17 | 31 | 32 | 35 | 35 | 41 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | – | – | – | 24 | 28 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
940 Original Medicare patients in 2024. Average age 75 · Under 65 10% · 85 and older 16% · Women 55% · Also on Medicaid 30% · Health risk score 1.65. Above the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 69% · Depression 33% · Chronic kidney disease 28% · Stroke 28% · Diabetes 26% · Dementia 24% · Coronary heart disease 22% · Atrial fibrillation 21% · Heart failure 17% · Cancer 16% · COPD 13%.
The office billed $1,513,029, Medicare allowed $563,817 and paid $427,284; for 47,411 services of 37 kinds; $220,784 of it was for drugs given in the office and $206,500 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 940 | 47,411 | 75 | 1.65 | $1,513,029 | $427,284 |
| 2023 | 913 | 44,093 | 75 | 1.67 | $1,367,823 | $405,461 |
| 2022 | 938 | 39,678 | 74 | 1.58 | $1,280,269 | $383,698 |
| 2021 | 926 | 29,105 | 74 | 1.70 | $1,081,908 | $322,508 |
| 2020 | 924 | 26,878 | 73 | 1.78 | $1,046,101 | $297,742 |
| 2019 | 954 | 20,184 | 74 | 1.84 | $978,941 | $267,284 |
| 2018 | 930 | 25,325 | 73 | 1.88 | $1,041,929 | $293,449 |
| 2017 | 935 | 22,220 | 73 | 1.92 | $898,875 | $258,931 |
| 2016 | 887 | 16,310 | 73 | 1.80 | $825,982 | $224,775 |
| 2015 | 847 | 16,376 | 73 | 1.85 | $785,129 | $219,437 |
| 2014 | 845 | 15,774 | 73 | 1.80 | $771,496 | $206,746 |
| 2013 | 800 | 11,753 | 73 | 1.83 | $683,221 | $182,705 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Botox | 85 | $192,817 | None |
| Short return visit (20+ min) | 358 | $42,379 | $74 |
| Return visit (30+ min) | 199 | $27,166 | $106 |
| New patient visit (60+ min) | 100 | $19,302 | $193 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 107 | $15,839 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 147 | $15,666 | $71 |
| Long return visit (40+ min) | 85 | $14,396 | $156 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 28 | $11,185 | $140 |
| New patient visit (45+ min) | 56 | $7,523 | $134 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 20 | $7,422 | $135 |
| Face injection for nerve paralysis | 14 | $6,153 | $150 |
| Short return visit | 61 | $5,305 | $51 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 18 | $4,813 | $138 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 65 | $3,913 | $44 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,700 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $2,704 | $104 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 13 | $2,415 | $86 |
| Measurement of brain wave activity (eeg), awake and drowsy | 29 | $1,492 | $50 |
2022: 18 services
| Botox | 77 | $172,603 | None |
| Short return visit (20+ min) | 383 | $42,536 | $72 |
| Return visit (30+ min) | 223 | $29,709 | $106 |
| New patient visit (60+ min) | 91 | $17,548 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 158 | $16,304 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $14,596 | $174 |
| Long return visit (40+ min) | 75 | $12,779 | $156 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 24 | $9,488 | $142 |
| New patient visit (45+ min) | 60 | $8,324 | $139 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 16 | $6,398 | $142 |
| Short return visit | 62 | $5,351 | $47 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 19 | $4,942 | $141 |
| Face injection for nerve paralysis | 12 | $4,911 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $4,361 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 36 | $4,259 | $115 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 66 | $3,190 | $34 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 12 | $2,117 | $88 |
| Measurement of brain wave activity (eeg), awake and drowsy | 29 | $1,407 | $49 |
2021: 20 services
| Botox | 61 | $128,612 | None |
| Short return visit (20+ min) | 333 | $37,990 | $73 |
| Return visit (30+ min) | 201 | $30,082 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 204 | $20,252 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 93 | $16,057 | $173 |
| New patient visit (60+ min) | 59 | $10,930 | $185 |
| Long return visit (40+ min) | 56 | $9,960 | $161 |
| New patient visit (45+ min) | 74 | $9,636 | $130 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 14 | $6,129 | $136 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 50 | $6,038 | $121 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 19 | $5,936 | $129 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 106 | $5,516 | $34 |
| Short return visit | 44 | $4,615 | $49 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 17 | $4,393 | $137 |
| Face injection for nerve paralysis | 12 | $4,100 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,313 | $92 |
| Measurement of brain wave activity (eeg), awake and drowsy | 52 | $2,615 | $49 |
| Critical care, first 30-74 minutes | 11 | $1,844 | $168 |
| New patient visit (30+ min) | 15 | $1,159 | $77 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | 12 | $351 | $15 |
2020: 24 services
| Botox | 57 | $111,595 | None |
| Short return visit (20+ min) | 356 | $34,365 | $62 |
| Return visit (30+ min) | 181 | $22,055 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 198 | $21,983 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $18,695 | $180 |
| New patient visit (45+ min) | 87 | $10,706 | $123 |
| New patient visit (60+ min) | 51 | $8,867 | $174 |
| Long return visit (40+ min) | 56 | $7,108 | $120 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 20 | $6,893 | $138 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 108 | $5,603 | $36 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $5,421 | $120 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 16 | $4,608 | $132 |
| Face injection for nerve paralysis | 11 | $4,265 | $158 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 15 | $4,230 | $136 |
| Short return visit | 47 | $3,603 | $38 |
| New patient visit (30+ min) | 31 | $2,966 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,616 | $97 |
| Critical care, first 30-74 minutes | 13 | $2,437 | $187 |
| Measurement of brain wave activity (eeg), awake and drowsy | 37 | $2,105 | $53 |
| Telephone medical discussion with physician, 11-20 minutes | 29 | $1,975 | $68 |
| Influenza vaccine split virus, preservative free | 18 | $1,091 | $61 |
| Telephone medical discussion with physician, 5-10 minutes | 11 | $533 | $44 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | 16 | $522 | $15 |
| Administration of influenza virus vaccine | 23 | $473 | $21 |
2019: 19 services
| Botox | 50 | $83,278 | None |
| Short return visit (20+ min) | 339 | $30,041 | $60 |
| Return visit (30+ min) | 191 | $23,684 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 210 | $22,102 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 109 | $19,632 | $178 |
| New patient visit (60+ min) | 85 | $14,351 | $169 |
| New patient visit (45+ min) | 92 | $11,363 | $124 |
| Long return visit (40+ min) | 81 | $11,243 | $125 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 64 | $7,871 | $123 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 113 | $6,319 | $35 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 17 | $5,882 | $120 |
| Face injection for nerve paralysis | 14 | $3,977 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $3,936 | $94 |
| Measurement of brain wave activity (eeg), awake and drowsy | 54 | $3,163 | $54 |
| Short return visit | 39 | $3,003 | $39 |
| Influenza vaccine split virus, preservative free | 41 | $2,229 | $53 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 12 | $2,184 | $128 |
| Administration of influenza virus vaccine | 44 | $908 | $20 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | 16 | $433 | $17 |
2018: 19 services
| Botox | 47 | $101,358 | None |
| Short return visit (20+ min) | 293 | $24,591 | $57 |
| Return visit (30+ min) | 189 | $23,226 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 123 | $22,084 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 195 | $19,854 | $64 |
| New patient visit (60+ min) | 79 | $14,184 | $180 |
| New patient visit (45+ min) | 80 | $11,123 | $139 |
| Long return visit (40+ min) | 60 | $8,416 | $124 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 70 | $8,104 | $114 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 127 | $7,026 | $34 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 15 | $6,253 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $4,910 | $93 |
| Face injection for nerve paralysis | 11 | $4,842 | $134 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 14 | $3,783 | $130 |
| Short return visit | 38 | $3,540 | $37 |
| Measurement of brain wave activity (eeg), awake and drowsy | 50 | $2,552 | $50 |
| Critical care, first 30-74 minutes | 13 | $2,380 | $183 |
| Influenza vaccine split virus, preservative free | 47 | $2,059 | $44 |
| Administration of influenza virus vaccine | 51 | $1,290 | $25 |
2017: 18 services
| Botox | 47 | $86,746 | None |
| Short return visit (20+ min) | 329 | $27,276 | $54 |
| Return visit (30+ min) | 204 | $24,570 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 93 | $16,468 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 167 | $13,346 | $63 |
| New patient visit (45+ min) | 93 | $11,778 | $127 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 87 | $10,492 | $119 |
| Long return visit (40+ min) | 60 | $7,843 | $119 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 155 | $7,506 | $33 |
| New patient visit (60+ min) | 47 | $7,188 | $153 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 17 | $5,945 | $117 |
| Face injection for nerve paralysis | 12 | $3,698 | $128 |
| Short return visit | 46 | $3,127 | $34 |
| Measurement of brain wave activity (eeg), awake and drowsy | 56 | $2,877 | $50 |
| Influenza vaccine split virus, preservative free | 64 | $2,822 | $44 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $2,739 | $91 |
| Administration of influenza virus vaccine | 73 | $2,270 | $31 |
| Measurement of brain wave activity (eeg), in coma or asleep | 12 | $725 | $48 |
2016: 15 services
| Botox | 34 | $57,994 | None |
| Return visit (30+ min) | 233 | $28,826 | $84 |
| Short return visit (20+ min) | 315 | $27,497 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 169 | $15,171 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 89 | $15,110 | $168 |
| New patient visit (45+ min) | 111 | $13,554 | $122 |
| New patient visit (60+ min) | 55 | $9,357 | $170 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 154 | $8,415 | $34 |
| Long return visit (40+ min) | 53 | $7,640 | $119 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 60 | $6,964 | $114 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 12 | $4,536 | $116 |
| Face injection for nerve paralysis | 11 | $4,028 | $61 |
| Short return visit | 39 | $2,786 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $2,513 | $84 |
| Measurement of brain wave activity (eeg), awake and drowsy | 42 | $2,228 | $50 |
2015: 16 services
| Botox | 38 | $58,261 | None |
| Short return visit (20+ min) | 335 | $27,963 | $56 |
| Return visit (30+ min) | 185 | $22,119 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $17,854 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 162 | $14,275 | $62 |
| New patient visit (45+ min) | 98 | $12,945 | $132 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 90 | $10,196 | $112 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 147 | $10,001 | $33 |
| Long return visit (40+ min) | 60 | $8,540 | $119 |
| New patient visit (60+ min) | 41 | $7,243 | $177 |
| Face injection for nerve paralysis | 11 | $3,317 | $133 |
| Short return visit | 35 | $2,597 | $37 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 12 | $2,506 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $2,127 | $89 |
| Measurement of brain wave activity (eeg), awake and drowsy | 41 | $2,072 | $49 |
| Measurement of brain wave activity (eeg), in coma or asleep | 11 | $706 | $50 |
2014: 16 services
| Botox | 29 | $54,957 | None |
| Short return visit (20+ min) | 319 | $27,023 | $56 |
| Return visit (30+ min) | 206 | $24,022 | $83 |
| New patient visit (45+ min) | 131 | $16,711 | $128 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 159 | $13,934 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 105 | $12,357 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $10,661 | $172 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 145 | $9,455 | $33 |
| New patient visit (60+ min) | 34 | $5,942 | $175 |
| Long return visit (40+ min) | 40 | $4,982 | $119 |
| Measurement of brain wave activity (eeg), awake and drowsy | 46 | $2,424 | $50 |
| Short return visit | 24 | $1,582 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,071 | $89 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 13 | $655 | $50 |
| Measurement of brain wave activity (eeg), in coma or asleep | 11 | $604 | $50 |
| Measurement of brain wave activity (eeg), awake and asleep | 12 | $589 | $49 |
2013: 15 services
| Botox | 25 | $37,395 | None |
| Short return visit (20+ min) | 308 | $27,255 | $53 |
| Return visit (30+ min) | 188 | $24,149 | $85 |
| New patient visit (45+ min) | 148 | $19,446 | $131 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 129 | $14,298 | $110 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 167 | $11,645 | $32 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 117 | $9,827 | $60 |
| Long return visit (40+ min) | 41 | $5,179 | $115 |
| Injection of chemical for destruction of arms legs and/or torso muscles | 14 | $4,807 | $166 |
| New patient visit (60+ min) | 26 | $4,519 | $174 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,868 | $159 |
| Measurement of brain wave activity (eeg), awake and drowsy | 36 | $1,894 | $49 |
| New patient visit (30+ min) | 15 | $1,258 | $84 |
| Short return visit | 14 | $874 | $35 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 11 | $585 | $49 |
Medicaid work
$98,009 in 2024
Medicaid paid $98,009 for 173 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Botox | 102 | $97,539 |
| Return visit (30+ min) | 58 | $469 |
| Chemodenervation of muscle(s); muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (eg, for chronic migraine) | 13 | $0 |
| 2024 | 173 | 3 | 20 | $98,009 |
| 2023 | 428 | 4 | 23 | $112,776 |
| 2022 | 418 | 5 | 27 | $31,639 |
| 2021 | 413 | 6 | 23 | $3,427 |
| 2020 | 330 | 3 | 22 | $3,077 |
| 2019 | 343 | 3 | 24 | $2,644 |
| 2018 | 517 | 5 | 33 | $2,310 |
See the largest Medicaid services in earlier years
2023
| Botox | 118 | $109,102 |
| Return visit (30+ min) | 161 | $1,912 |
| Short return visit (20+ min) | 112 | $921 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 37 | $842 |
2022
| Botox | 38 | $26,071 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 105 | $3,304 |
| Short return visit (20+ min) | 96 | $1,431 |
| Return visit (30+ min) | 166 | $833 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 13 | $0 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 109 | $2,015 |
| Short return visit (20+ min) | 126 | $545 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 35 | $484 |
| Return visit (30+ min) | 114 | $383 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 17 | $0 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 12 | $0 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 87 | $2,372 |
| Short return visit (20+ min) | 154 | $609 |
| Return visit (30+ min) | 89 | $96 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 71 | $1,377 |
| Short return visit (20+ min) | 128 | $740 |
| Return visit (30+ min) | 144 | $528 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 68 | $868 |
| Short return visit (20+ min) | 227 | $705 |
| Return visit (30+ min) | 180 | $427 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 26 | $231 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 16 | $81 |
Drugs they prescribed that Part D paid
$2,810,374
Pharmacies billed $2,810,374 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (29 of 7,100) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
5,989 generic and fewer than 11 brand-name prescriptions · $2,810,374 in drug cost · 11 antibiotic prescriptions · 288 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rytary | Parkinson's | 419 | $550,710 | $1,314 |
| Nuplazid | Parkinson's psychosis | 74 | $423,125 | $5,718 |
| Privigen | Immune globulin | 11 | $232,160 | $21,105 |
| Nourianz | None | 68 | $171,481 | $2,522 |
| Radicava Ors | None | 12 | $162,186 | $13,515 |
See all 91 drugs
| Rytary | Parkinson's | 419 | $550,710 | $1,314 |
| Nuplazid | Parkinson's psychosis | 74 | $423,125 | $5,718 |
| Privigen | Immune globulin | 11 | $232,160 | $21,105 |
| Nourianz | None | 68 | $171,481 | $2,522 |
| Radicava Ors | None | 12 | $162,186 | $13,515 |
| Ingrezza | None | 14 | $153,876 | $10,991 |
| Austedo | None | 21 | $130,781 | $6,228 |
| Aptiom | None | 14 | $96,006 | $6,858 |
| Copaxone | None | 16 | $91,011 | $5,688 |
| Rasagiline Mesylate | None | 362 | $60,081 | $166 |
| Nurtec Odt | None | 37 | $48,050 | $1,299 |
| Myrbetriq | None | 51 | $43,972 | $862 |
| Teriflunomide | None | 14 | $37,834 | $2,702 |
| Carbidopa-Levodopa | None | 902 | $31,396 | $35 |
| Neupro | None | 30 | $29,185 | $973 |
| Ubrelvy | None | 12 | $24,657 | $2,055 |
| Lacosamide | None | 56 | $24,447 | $437 |
| Linzess | None | 18 | $22,797 | $1,267 |
| Azilect | None | 11 | $20,884 | $1,899 |
| Qulipta | None | 19 | $20,581 | $1,083 |
| Carbidopa | None | 52 | $19,854 | $382 |
| Aimovig | Migraine | 11 | $19,162 | $1,742 |
| Eliquis | None | 19 | $18,640 | $981 |
| Memantine | None | 444 | $18,270 | $41 |
| Rivastigmine | None | 66 | $16,448 | $249 |
| Midodrine | None | 196 | $14,447 | $74 |
| Carbidopa-Levodopa-Entacapone | None | 41 | $12,383 | $302 |
| Entacapone | None | 49 | $10,207 | $208 |
| Lyrica | None | 11 | $9,126 | $830 |
| Pramipexole Er | None | 13 | $7,345 | $565 |
| Carbidopa-Levodopa Er | None | 195 | $6,820 | $35 |
| Levetiracetam | None | 177 | $5,527 | $31 |
| Donepezil | None | 438 | $5,463 | $12 |
| Gabapentin | None | 280 | $5,223 | $19 |
| Sumatriptan | None | 57 | $5,133 | $90 |
| Fludrocortisone Acetate | None | 171 | $4,756 | $28 |
| Amantadine | None | 116 | $3,584 | $31 |
| Primidone | None | 128 | $3,194 | $25 |
| Pramipexole Dihydrochloride | None | 102 | $3,007 | $29 |
| Quetiapine | None | 159 | $2,997 | $19 |
| Pregabalin | None | 129 | $2,963 | $23 |
| Droxidopa | None | 11 | $2,954 | $269 |
| Divalproex Sodium Er | None | 19 | $2,628 | $138 |
| Propranolol | None | 130 | $2,482 | $19 |
| Pyridostigmine | None | 33 | $2,444 | $74 |
| Memantine Hcl Er | None | 19 | $2,252 | $119 |
| Venlafaxine Hcl Er | None | 42 | $2,217 | $53 |
| Baclofen | None | 112 | $2,188 | $20 |
| Mirtazapine | None | 141 | $2,010 | $14 |
| Topiramate | None | 22 | $1,746 | $79 |
| Lamotrigine | None | 107 | $1,681 | $16 |
| Solifenacin | None | 60 | $1,583 | $26 |
| Duloxetine | None | 72 | $1,381 | $19 |
| Divalproex | None | 17 | $1,297 | $76 |
| Escitalopram | None | 89 | $1,131 | $13 |
| Rivastigmine | None | 14 | $1,086 | $78 |
| Propranolol Hcl Er | None | 17 | $1,004 | $59 |
| Olanzapine | None | 16 | $982 | $61 |
| Clopidogrel | None | 45 | $822 | $18 |
| Trospium Chloride | None | 14 | $819 | $59 |
| Aripiprazole | None | 24 | $724 | $30 |
| Clonazepam | None | 78 | $610 | $8 |
| Trazodone | None | 30 | $585 | $19 |
| Ipratropium | None | 14 | $584 | $42 |
| Rizatriptan | None | 41 | $528 | $13 |
| Modafinil | None | 17 | $515 | $30 |
| Clozapine | None | 19 | $511 | $27 |
| Nortriptyline | None | 41 | $492 | $12 |
| Naratriptan | None | 11 | $471 | $43 |
| Oxycodone | None | 11 | $445 | $40 |
| Olanzapine Odt | None | 23 | $444 | $19 |
| Bupropion Xl | None | 15 | $411 | $27 |
| Citalopram Hbr | None | 43 | $377 | $9 |
| Trihexyphenidyl | None | 14 | $372 | $27 |
| Prednisone | None | 39 | $357 | $9 |
| Cyclobenzaprine | None | 16 | $315 | $20 |
| Tizanidine | None | 11 | $303 | $28 |
| Zolpidem | None | 39 | $275 | $7 |
| Temazepam | None | 17 | $270 | $16 |
| Diazepam | None | 38 | $222 | $6 |
| Lithium Carbonate | None | 16 | $218 | $14 |
| Atorvastatin | None | 15 | $215 | $14 |
| Celecoxib | None | 17 | $203 | $12 |
| Ondansetron Odt | None | 11 | $189 | $17 |
| Indomethacin | None | 14 | $172 | $12 |
| Pantoprazole | None | 16 | $170 | $11 |
| Sertraline | None | 27 | $149 | $6 |
| Tramadol | None | 16 | $141 | $9 |
| Lorazepam | None | 38 | $113 | $3 |
| Sulfamethoxazole-Trimethoprim | None | 11 | $85 | $8 |
| Meloxicam | None | 18 | $29 | $2 |
Year by year
| 2024 | 7,100 | 819 | 0% (29) | None | $2,810,374 |
| 2023 | 6,154 | 766 | 0% (14) | None | $2,745,540 |
| 2022 | 6,100 | 708 | 0% (24) | None | $2,614,601 |
| 2021 | 6,079 | 655 | 0% (17) | None | $2,552,932 |
| 2020 | 5,842 | 619 | 0% (20) | 18% | $2,546,722 |
| 2019 | 5,399 | 570 | 0% (17) | 16% | $2,015,269 |
| 2018 | 6,173 | 624 | 0% (19) | 19% | $2,146,880 |
| 2017 | 7,160 | 646 | None | 20% | $1,933,312 |
| 2016 | 6,845 | 632 | 0% (21) | None | $1,682,245 |
| 2015 | 6,109 | 566 | 1% (38) | None | $1,134,793 |
| 2014 | 6,057 | 576 | 0% (22) | 26% | $1,005,861 |
| 2013 | 5,411 | 506 | 1% (25) | 29% | $975,075 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 83 drugs
| Rytary | Parkinson's | 307 | $461,729 | $1,504 |
| Privigen | Immune globulin | 13 | $259,473 | $19,959 |
| Nuplazid | Parkinson's psychosis | 51 | $250,273 | $4,907 |
| Austedo | None | 21 | $179,657 | $8,555 |
| Ingrezza | None | 14 | $151,281 | $10,806 |
| Nourianz | None | 62 | $141,614 | $2,284 |
| Northera | None | 11 | $114,693 | $10,427 |
| Rasagiline Mesylate | None | 258 | $93,031 | $361 |
| Copaxone | None | 15 | $86,110 | $5,741 |
| Aptiom | None | 12 | $70,423 | $5,869 |
| Nurtec Odt | None | 30 | $49,297 | $1,643 |
| Neupro | None | 49 | $47,758 | $975 |
| Carbidopa | None | 30 | $44,077 | $1,469 |
| Carbidopa-Levodopa | None | 797 | $40,650 | $51 |
| Horizant | None | 12 | $37,262 | $3,105 |
| Myrbetriq | None | 33 | $33,477 | $1,014 |
| Emgality | Migraine | 24 | $30,381 | $1,266 |
| Rivastigmine | None | 76 | $24,994 | $329 |
| Pramipexole Er | None | 19 | $21,432 | $1,128 |
| Qulipta | None | 19 | $19,627 | $1,033 |
| Linzess | None | 14 | $18,719 | $1,337 |
| Ubrelvy | None | 14 | $18,057 | $1,290 |
| Entacapone | None | 22 | $16,167 | $735 |
| Memantine | None | 377 | $16,070 | $43 |
| Lacosamide | None | 41 | $13,450 | $328 |
| Carbidopa-Levodopa Er | None | 142 | $12,378 | $87 |
| Midodrine | None | 110 | $12,061 | $110 |
| Lyrica | None | 11 | $10,308 | $937 |
| Carbidopa-Levodopa-Entacapone | None | 34 | $9,993 | $294 |
| Gabapentin | None | 304 | $9,230 | $30 |
| Levetiracetam | None | 174 | $7,932 | $46 |
| Donepezil | None | 315 | $6,375 | $20 |
| Pregabalin | None | 117 | $5,177 | $44 |
| Amantadine | None | 99 | $5,110 | $52 |
| Fludrocortisone Acetate | None | 111 | $4,631 | $42 |
| Baclofen | None | 134 | $4,327 | $32 |
| Primidone | None | 127 | $4,054 | $32 |
| Propranolol | None | 104 | $3,911 | $38 |
| Lamotrigine | None | 130 | $3,595 | $28 |
| Pramipexole Dihydrochloride | None | 77 | $3,279 | $43 |
| Quetiapine | None | 94 | $3,171 | $34 |
| Pyridostigmine | None | 22 | $3,017 | $137 |
| Zonisamide | None | 34 | $2,567 | $75 |
| Mirtazapine | None | 117 | $2,531 | $22 |
| Memantine Hcl Er | None | 13 | $2,395 | $184 |
| Sumatriptan | None | 45 | $2,169 | $48 |
| Duloxetine | None | 74 | $2,082 | $28 |
| Solifenacin | None | 24 | $2,006 | $84 |
| Acetazolamide | None | 12 | $1,634 | $136 |
| Divalproex | None | 32 | $1,613 | $50 |
| Escitalopram | None | 73 | $1,417 | $19 |
| Trospium Chloride | None | 23 | $1,295 | $56 |
| Protriptyline | None | 13 | $1,255 | $97 |
| Olanzapine | None | 25 | $1,253 | $50 |
| Olanzapine Odt | None | 36 | $1,235 | $34 |
| Carbamazepine Er | None | 13 | $1,223 | $94 |
| Clonazepam | None | 99 | $890 | $9 |
| Clopidogrel | None | 40 | $846 | $21 |
| Naratriptan | None | 11 | $736 | $67 |
| Clozapine | None | 17 | $713 | $42 |
| Nortriptyline | None | 40 | $705 | $18 |
| Topiramate | None | 16 | $546 | $34 |
| Celecoxib | None | 20 | $543 | $27 |
| Ondansetron | None | 19 | $543 | $29 |
| Prednisone | None | 55 | $538 | $10 |
| Atorvastatin | None | 36 | $524 | $15 |
| Propranolol Hcl Er | None | 14 | $501 | $36 |
| Cyclobenzaprine | None | 24 | $465 | $19 |
| Tizanidine | None | 36 | $451 | $13 |
| Rizatriptan | None | 19 | $421 | $22 |
| Ropinirole | None | 11 | $363 | $33 |
| Bupropion Xl | None | 27 | $356 | $13 |
| Diazepam | None | 45 | $329 | $7 |
| Lorazepam | None | 37 | $311 | $8 |
| Citalopram Hbr | None | 27 | $262 | $10 |
| Trazodone | None | 15 | $235 | $16 |
| Temazepam | None | 14 | $207 | $15 |
| Trihexyphenidyl | None | 19 | $200 | $11 |
| Sulfamethoxazole-Trimethoprim | None | 16 | $192 | $12 |
| Amlodipine Besylate | None | 18 | $148 | $8 |
| Zolpidem | None | 16 | $117 | $7 |
| Pantoprazole | None | 11 | $116 | $11 |
| Sertraline | None | 14 | $107 | $8 |
2022: 89 drugs
| Rytary | Parkinson's | 300 | $402,829 | $1,343 |
| Privigen | Immune globulin | 14 | $259,521 | $18,537 |
| Nuplazid | Parkinson's psychosis | 30 | $241,442 | $8,048 |
| Aubagio | None | 15 | $200,479 | $13,365 |
| Austedo | None | 13 | $127,898 | $9,838 |
| Rasagiline Mesylate | None | 301 | $119,746 | $398 |
| Northera | None | 12 | $117,613 | $9,801 |
| Nourianz | None | 46 | $85,063 | $1,849 |
| Copaxone | None | 14 | $80,370 | $5,741 |
| Myrbetriq | None | 89 | $59,359 | $667 |
| Gocovri | None | 18 | $58,575 | $3,254 |
| Tasigna | None | 12 | $54,720 | $4,560 |
| Aptiom | None | 13 | $50,680 | $3,898 |
| Vimpat | None | 31 | $41,176 | $1,328 |
| Carbidopa-Levodopa | None | 798 | $40,319 | $51 |
| Neupro | None | 46 | $37,174 | $808 |
| Rivastigmine | None | 90 | $33,022 | $367 |
| Azilect | None | 14 | $32,783 | $2,342 |
| Carbidopa | None | 17 | $28,874 | $1,698 |
| Ubrelvy | None | 26 | $26,264 | $1,010 |
| Emgality | Migraine | 13 | $23,098 | $1,777 |
| Briviact | None | 14 | $19,666 | $1,405 |
| Aimovig | Migraine | 15 | $17,160 | $1,144 |
| Memantine | None | 303 | $16,298 | $54 |
| Entacapone | None | 25 | $14,751 | $590 |
| Pramipexole Er | None | 13 | $14,018 | $1,078 |
| Linzess | None | 15 | $12,105 | $807 |
| Gabapentin | None | 317 | $11,030 | $35 |
| Carbidopa-Levodopa Er | None | 110 | $10,727 | $98 |
| Midodrine | None | 103 | $10,616 | $103 |
| Lacosamide | None | 24 | $10,566 | $440 |
| Lyrica | None | 12 | $10,386 | $866 |
| Droxidopa | None | 13 | $10,251 | $789 |
| Clobazam | None | 12 | $8,364 | $697 |
| Carbidopa-Levodopa-Entacapone | None | 26 | $7,617 | $293 |
| Baclofen | None | 152 | $6,249 | $41 |
| Pregabalin | None | 110 | $6,209 | $56 |
| Levetiracetam | None | 175 | $5,896 | $34 |
| Donepezil | None | 288 | $5,460 | $19 |
| Amantadine | None | 77 | $5,169 | $67 |
| Sumatriptan | None | 33 | $5,079 | $154 |
| Fludrocortisone Acetate | None | 134 | $4,524 | $34 |
| Memantine Hcl Er | None | 20 | $4,403 | $220 |
| Primidone | None | 116 | $4,153 | $36 |
| Pramipexole Dihydrochloride | None | 87 | $3,577 | $41 |
| Propranolol | None | 89 | $3,216 | $36 |
| Duloxetine | None | 78 | $3,125 | $40 |
| Mirtazapine | None | 165 | $2,977 | $18 |
| Acetazolamide | None | 16 | $2,955 | $185 |
| Aripiprazole | None | 18 | $2,828 | $157 |
| Lamotrigine | None | 113 | $2,370 | $21 |
| Quetiapine | None | 107 | $2,326 | $22 |
| Solifenacin | None | 23 | $2,169 | $94 |
| Carbamazepine Er | None | 27 | $2,167 | $80 |
| Trospium Chloride | None | 17 | $1,885 | $111 |
| Zonisamide | None | 34 | $1,777 | $52 |
| Propranolol Hcl Er | None | 12 | $1,518 | $126 |
| Divalproex | None | 16 | $1,464 | $91 |
| Celecoxib | None | 26 | $1,394 | $54 |
| Pyridostigmine | None | 13 | $1,278 | $98 |
| Olanzapine Odt | None | 15 | $1,277 | $85 |
| Carbamazepine | None | 13 | $822 | $63 |
| Clopidogrel | None | 52 | $803 | $15 |
| Escitalopram | None | 51 | $782 | $15 |
| Atorvastatin | None | 73 | $740 | $10 |
| Clozapine | None | 25 | $739 | $30 |
| Cyclobenzaprine | None | 37 | $658 | $18 |
| Nortriptyline | None | 34 | $640 | $19 |
| Olanzapine | None | 11 | $599 | $54 |
| Clonazepam | None | 91 | $569 | $6 |
| Prednisone | None | 53 | $537 | $10 |
| Fluvoxamine Maleate | None | 12 | $524 | $44 |
| Pantoprazole | None | 16 | $487 | $30 |
| Valacyclovir | None | 11 | $351 | $32 |
| Trazodone | None | 30 | $315 | $10 |
| Topiramate | None | 24 | $299 | $12 |
| Lorazepam | None | 51 | $278 | $5 |
| Amitriptyline | None | 13 | $264 | $20 |
| Diazepam | None | 33 | $245 | $7 |
| Pravastatin | None | 11 | $244 | $22 |
| Sertraline | None | 15 | $228 | $15 |
| Zolpidem | None | 19 | $219 | $12 |
| Ibuprofen | None | 19 | $217 | $11 |
| Tramadol | None | 21 | $184 | $9 |
| Ropinirole | None | 11 | $140 | $13 |
| Temazepam | None | 12 | $135 | $11 |
| Sulfamethoxazole-Trimethoprim | None | 13 | $131 | $10 |
| Citalopram Hbr | None | 30 | $115 | $4 |
| Metoprolol | None | 14 | $97 | $7 |
2021: 88 drugs
| Rytary | Parkinson's | 362 | $377,156 | $1,042 |
| Nuplazid | Parkinson's psychosis | 55 | $321,744 | $5,850 |
| Privigen | Immune globulin | 12 | $200,347 | $16,696 |
| Austedo | None | 12 | $142,065 | $11,839 |
| Rasagiline Mesylate | None | 306 | $132,171 | $432 |
| Northera | None | 16 | $114,096 | $7,131 |
| Aubagio | None | 12 | $103,299 | $8,608 |
| Copaxone | None | 15 | $92,706 | $6,180 |
| Gocovri | None | 24 | $86,519 | $3,605 |
| Ingrezza | None | 11 | $74,660 | $6,787 |
| Vimpat | None | 45 | $71,150 | $1,581 |
| Inbrija | None | 21 | $56,078 | $2,670 |
| Carbidopa-Levodopa | None | 767 | $52,382 | $68 |
| Myrbetriq | None | 92 | $52,064 | $566 |
| Neupro | None | 49 | $36,914 | $753 |
| Azilect | None | 19 | $34,686 | $1,826 |
| Horizant | None | 13 | $31,996 | $2,461 |
| Nourianz | None | 14 | $21,622 | $1,544 |
| Rivastigmine | None | 78 | $21,042 | $270 |
| Mirapex Er | None | 14 | $20,189 | $1,442 |
| Emgality | Migraine | 23 | $16,401 | $713 |
| Memantine | None | 270 | $16,379 | $61 |
| Linzess | None | 15 | $13,336 | $889 |
| Carbidopa | None | 12 | $12,666 | $1,056 |
| Entacapone | None | 46 | $12,651 | $275 |
| Pramipexole Er | None | 13 | $11,662 | $897 |
| Carbidopa-Levodopa-Entacapone | None | 34 | $11,279 | $332 |
| Carbidopa-Levodopa Er | None | 115 | $11,088 | $96 |
| Dihydroergotamine Mesylate | None | 11 | $11,085 | $1,008 |
| Aimovig | Migraine | 16 | $10,111 | $632 |
| Lyrica | None | 12 | $8,980 | $748 |
| Sumatriptan | None | 52 | $8,857 | $170 |
| Midodrine | None | 108 | $8,785 | $81 |
| Levetiracetam | None | 183 | $7,693 | $42 |
| Gabapentin | None | 298 | $6,580 | $22 |
| Pregabalin | None | 110 | $6,503 | $59 |
| Belsomra | None | 11 | $6,357 | $578 |
| Memantine Hcl Er | None | 26 | $6,130 | $236 |
| Amantadine | None | 97 | $5,327 | $55 |
| Fludrocortisone Acetate | None | 129 | $5,259 | $41 |
| Baclofen | None | 141 | $4,792 | $34 |
| Propranolol | None | 101 | $4,723 | $47 |
| Donepezil | None | 305 | $4,408 | $14 |
| Depakote Er | None | 12 | $4,303 | $359 |
| Lamotrigine | None | 103 | $4,252 | $41 |
| Aripiprazole | None | 17 | $3,060 | $180 |
| Primidone | None | 109 | $2,956 | $27 |
| Mirtazapine | None | 127 | $2,386 | $19 |
| Pramipexole Dihydrochloride | None | 72 | $2,300 | $32 |
| Propranolol Hcl Er | None | 23 | $2,237 | $97 |
| Solifenacin | None | 42 | $2,162 | $51 |
| Carbamazepine | None | 15 | $1,801 | $120 |
| Quetiapine | None | 130 | $1,645 | $13 |
| Zonisamide | None | 32 | $1,618 | $51 |
| Divalproex | None | 22 | $1,568 | $71 |
| Olanzapine Odt | None | 24 | $1,492 | $62 |
| Venlafaxine Hcl Er | None | 27 | $1,359 | $50 |
| Clobazam | None | 12 | $1,261 | $105 |
| Duloxetine | None | 62 | $1,182 | $19 |
| Oxcarbazepine | None | 14 | $987 | $70 |
| Clozapine | None | 25 | $854 | $34 |
| Clopidogrel | None | 48 | $828 | $17 |
| Cyclobenzaprine | None | 23 | $744 | $32 |
| Escitalopram | None | 59 | $733 | $12 |
| Modafinil | None | 13 | $686 | $53 |
| Sertraline | None | 38 | $634 | $17 |
| Prednisone | None | 62 | $633 | $10 |
| Prazosin | None | 15 | $616 | $41 |
| Naratriptan | None | 12 | $496 | $41 |
| Pantoprazole | None | 17 | $469 | $28 |
| Divalproex Sodium Er | None | 11 | $468 | $43 |
| Nortriptyline | None | 35 | $457 | $13 |
| Clonazepam | None | 64 | $442 | $7 |
| Atorvastatin | None | 34 | $413 | $12 |
| Diazepam | None | 42 | $279 | $7 |
| Lorazepam | None | 48 | $272 | $6 |
| Trazodone | None | 31 | $270 | $9 |
| Zolpidem | None | 26 | $264 | $10 |
| Famotidine | None | 26 | $261 | $10 |
| Ibuprofen | None | 25 | $253 | $10 |
| Topiramate | None | 34 | $216 | $6 |
| Amitriptyline | None | 20 | $208 | $10 |
| Tizanidine | None | 15 | $165 | $11 |
| Citalopram Hbr | None | 30 | $138 | $5 |
| Trihexyphenidyl | None | 19 | $138 | $7 |
| Tramadol | None | 16 | $129 | $8 |
| Sulfamethoxazole-Trimethoprim | None | 12 | $83 | $7 |
| Furosemide | None | 12 | $26 | $2 |
2020: 84 drugs
| Nuplazid | Parkinson's psychosis | 73 | $384,019 | $5,261 |
| Rytary | Parkinson's | 310 | $279,935 | $903 |
| Northera | None | 12 | $204,370 | $17,031 |
| Austedo | None | 21 | $201,317 | $9,587 |
| Rasagiline Mesylate | None | 333 | $195,189 | $586 |
| Gocovri | None | 34 | $112,840 | $3,319 |
| Ingrezza | None | 14 | $90,664 | $6,476 |
| Copaxone | None | 14 | $80,370 | $5,741 |
| Vimpat | None | 39 | $59,321 | $1,521 |
| Neupro | None | 51 | $48,185 | $945 |
| Carbidopa-Levodopa | None | 734 | $45,429 | $62 |
| Azilect | None | 36 | $44,413 | $1,234 |
| Inbrija | None | 21 | $43,417 | $2,067 |
| Myrbetriq | None | 52 | $31,474 | $605 |
| Aptiom | None | 11 | $28,510 | $2,592 |
| Rivastigmine | None | 86 | $24,064 | $280 |
| Pramipexole Er | None | 15 | $19,465 | $1,298 |
| Carbidopa | None | 29 | $17,536 | $605 |
| Memantine | None | 333 | $14,049 | $42 |
| Carbidopa-Levodopa-Entacapone | None | 50 | $13,072 | $261 |
| Midodrine | None | 115 | $11,481 | $100 |
| Mirapex Er | None | 14 | $10,589 | $756 |
| Sumatriptan | None | 37 | $10,069 | $272 |
| Memantine Hcl Er | None | 35 | $9,765 | $279 |
| Entacapone | None | 28 | $9,080 | $324 |
| Carbidopa-Levodopa Er | None | 113 | $8,818 | $78 |
| Nuedexta | None | 11 | $7,227 | $657 |
| Emgality | Migraine | 11 | $6,490 | $590 |
| Xarelto | None | 12 | $5,744 | $479 |
| Levetiracetam | None | 157 | $5,282 | $34 |
| Pregabalin | None | 64 | $5,194 | $81 |
| Propranolol | None | 96 | $4,900 | $51 |
| Gabapentin | None | 250 | $4,741 | $19 |
| Fludrocortisone Acetate | None | 106 | $4,391 | $41 |
| Pramipexole Dihydrochloride | None | 113 | $4,333 | $38 |
| Donepezil | None | 363 | $4,278 | $12 |
| Amantadine | None | 75 | $4,049 | $54 |
| Depakote Er | None | 11 | $3,955 | $360 |
| Baclofen | None | 122 | $3,847 | $32 |
| Modafinil | None | 11 | $3,344 | $304 |
| Clobazam | None | 14 | $2,890 | $206 |
| Dantrolene | None | 20 | $2,776 | $139 |
| Lamotrigine | None | 102 | $2,769 | $27 |
| Propranolol Hcl Er | None | 18 | $2,702 | $150 |
| Dilantin | None | 11 | $2,624 | $239 |
| Primidone | None | 99 | $2,623 | $26 |
| Carbatrol | None | 11 | $2,560 | $233 |
| Zonisamide | None | 46 | $2,496 | $54 |
| Carbamazepine | None | 19 | $2,021 | $106 |
| Mirtazapine | None | 98 | $1,734 | $18 |
| Lidocaine | None | 14 | $1,462 | $104 |
| Duloxetine | None | 47 | $1,196 | $25 |
| Nortriptyline | None | 60 | $1,104 | $18 |
| Quetiapine | None | 89 | $1,049 | $12 |
| Venlafaxine Hcl Er | None | 33 | $998 | $30 |
| Clozapine | None | 26 | $899 | $35 |
| Clopidogrel | None | 53 | $688 | $13 |
| Phenobarbital | None | 16 | $673 | $42 |
| Naratriptan | None | 17 | $634 | $37 |
| Olanzapine Odt | None | 28 | $612 | $22 |
| Escitalopram | None | 72 | $594 | $8 |
| Prednisone | None | 65 | $535 | $8 |
| Atorvastatin | None | 39 | $465 | $12 |
| Pantoprazole | None | 18 | $377 | $21 |
| Sertraline | None | 38 | $349 | $9 |
| Clonazepam | None | 75 | $329 | $4 |
| Tizanidine | None | 13 | $304 | $23 |
| Divalproex | None | 19 | $294 | $15 |
| Diazepam | None | 51 | $291 | $6 |
| Ondansetron Odt | None | 14 | $280 | $20 |
| Topiramate | None | 18 | $255 | $14 |
| Prazosin | None | 13 | $239 | $18 |
| Famotidine | None | 13 | $219 | $17 |
| Zolpidem | None | 23 | $205 | $9 |
| Trazodone | None | 23 | $187 | $8 |
| Lorazepam | None | 41 | $182 | $4 |
| Risperidone | None | 14 | $161 | $11 |
| Tramadol | None | 18 | $127 | $7 |
| Trihexyphenidyl | None | 17 | $117 | $7 |
| Citalopram Hbr | None | 27 | $103 | $4 |
| Buspirone | None | 16 | $76 | $5 |
| Paroxetine | None | 14 | $76 | $5 |
| Sulfamethoxazole-Trimethoprim | None | 11 | $72 | $7 |
| Amitriptyline | None | 11 | $71 | $6 |
2019: 76 drugs
| Nuplazid | Parkinson's psychosis | 66 | $242,199 | $3,670 |
| Privigen | Immune globulin | 11 | $220,965 | $20,088 |
| Rasagiline Mesylate | None | 387 | $207,586 | $536 |
| Northera | None | 15 | $205,192 | $13,679 |
| Austedo | None | 30 | $190,917 | $6,364 |
| Rytary | Parkinson's | 236 | $182,406 | $773 |
| Copaxone | None | 13 | $77,195 | $5,938 |
| Gocovri | None | 18 | $44,071 | $2,448 |
| Carbidopa-Levodopa | None | 759 | $35,513 | $47 |
| Aptiom | None | 17 | $35,453 | $2,085 |
| Rivastigmine | None | 89 | $33,860 | $380 |
| Vimpat | None | 20 | $33,515 | $1,676 |
| Neupro | None | 32 | $32,621 | $1,019 |
| Azilect | None | 34 | $29,531 | $869 |
| Myrbetriq | None | 42 | $23,715 | $565 |
| Exelon | None | 11 | $18,634 | $1,694 |
| Tetrabenazine | None | 12 | $17,480 | $1,457 |
| Carbidopa-Levodopa-Entacapone | None | 39 | $16,420 | $421 |
| Pramipexole Er | None | 18 | $15,038 | $835 |
| Lyrica | None | 22 | $14,746 | $670 |
| Memantine | None | 286 | $14,727 | $51 |
| Entacapone | None | 25 | $13,773 | $551 |
| Memantine Hcl Er | None | 39 | $13,466 | $345 |
| Mirapex Er | None | 18 | $11,727 | $651 |
| Clobazam | None | 12 | $10,023 | $835 |
| Carbidopa | None | 17 | $9,426 | $554 |
| Midodrine | None | 119 | $8,762 | $74 |
| Sumatriptan | None | 34 | $6,763 | $199 |
| Amantadine | None | 96 | $5,603 | $58 |
| Carbidopa-Levodopa Er | None | 84 | $4,978 | $59 |
| Levetiracetam | None | 128 | $4,444 | $35 |
| Depakote Er | None | 12 | $4,417 | $368 |
| Fludrocortisone Acetate | None | 144 | $4,345 | $30 |
| Gabapentin | None | 200 | $4,235 | $21 |
| Propranolol | None | 87 | $3,795 | $44 |
| Donepezil | None | 300 | $3,674 | $12 |
| Lamotrigine | None | 84 | $3,021 | $36 |
| Pramipexole Dihydrochloride | None | 114 | $2,870 | $25 |
| Pyridostigmine | None | 22 | $2,373 | $108 |
| Primidone | None | 126 | $2,372 | $19 |
| Baclofen | None | 94 | $2,364 | $25 |
| Propranolol Hcl Er | None | 22 | $2,187 | $99 |
| Duloxetine | None | 40 | $1,951 | $49 |
| Rivastigmine | None | 21 | $1,700 | $81 |
| Escitalopram | None | 119 | $1,686 | $14 |
| Mirtazapine | None | 65 | $1,668 | $26 |
| Zonisamide | None | 52 | $1,540 | $30 |
| Carbamazepine | None | 21 | $1,468 | $70 |
| Quetiapine | None | 57 | $1,357 | $24 |
| Phenobarbital | None | 25 | $1,196 | $48 |
| Trospium Chloride | None | 16 | $1,123 | $70 |
| Modafinil | None | 12 | $1,099 | $92 |
| Clozapine | None | 25 | $835 | $33 |
| Venlafaxine Hcl Er | None | 26 | $617 | $24 |
| Nortriptyline | None | 54 | $613 | $11 |
| Clonazepam | None | 62 | $553 | $9 |
| Atorvastatin | None | 34 | $536 | $16 |
| Naratriptan | None | 12 | $438 | $36 |
| Trihexyphenidyl | None | 26 | $422 | $16 |
| Oxcarbazepine | None | 12 | $411 | $34 |
| Trazodone | None | 35 | $409 | $12 |
| Topiramate | None | 46 | $406 | $9 |
| Prednisone | None | 38 | $396 | $10 |
| Clopidogrel | None | 35 | $381 | $11 |
| Buspirone | None | 28 | $377 | $13 |
| Ondansetron Odt | None | 17 | $344 | $20 |
| Divalproex | None | 24 | $335 | $14 |
| Oxybutynin Chloride | None | 11 | $273 | $25 |
| Sertraline | None | 33 | $269 | $8 |
| Diazepam | None | 40 | $263 | $7 |
| Famotidine | None | 13 | $261 | $20 |
| Lorazepam | None | 47 | $215 | $5 |
| Zolpidem | None | 16 | $157 | $10 |
| Citalopram Hbr | None | 16 | $136 | $9 |
| Tramadol | None | 17 | $120 | $7 |
| Alfuzosin Hcl Er | None | 11 | $106 | $10 |
2018: 81 drugs
| Rasagiline Mesylate | None | 498 | $328,876 | $660 |
| Northera | None | 21 | $229,797 | $10,943 |
| Nuplazid | Parkinson's psychosis | 77 | $215,533 | $2,799 |
| Privigen | Immune globulin | 11 | $194,460 | $17,678 |
| Rytary | Parkinson's | 257 | $182,827 | $711 |
| Tetrabenazine | None | 17 | $93,139 | $5,479 |
| Copaxone | None | 13 | $77,813 | $5,986 |
| Vimpat | None | 32 | $51,012 | $1,594 |
| Azilect | None | 62 | $44,965 | $725 |
| Ampyra | None | 12 | $43,336 | $3,611 |
| Rivastigmine | None | 109 | $42,337 | $388 |
| Carbidopa-Levodopa | None | 887 | $38,702 | $44 |
| Lyrica | None | 63 | $37,495 | $595 |
| Neupro | None | 45 | $36,198 | $804 |
| Aptiom | None | 16 | $23,656 | $1,479 |
| Entacapone | None | 33 | $20,173 | $611 |
| Mirapex Er | None | 12 | $19,210 | $1,601 |
| Myrbetriq | None | 40 | $18,318 | $458 |
| Carbidopa-Levodopa-Entacapone | None | 25 | $15,753 | $630 |
| Exelon | None | 14 | $15,718 | $1,123 |
| Memantine Hcl Er | None | 41 | $14,409 | $351 |
| Memantine | None | 242 | $13,689 | $57 |
| Onfi | None | 12 | $13,448 | $1,121 |
| Pramipexole Er | None | 13 | $11,636 | $895 |
| Amantadine | None | 97 | $11,116 | $115 |
| Carbidopa-Levodopa Er | None | 156 | $9,456 | $61 |
| Namenda Xr | None | 17 | $9,158 | $539 |
| Midodrine | None | 130 | $8,660 | $67 |
| Aspirin-Dipyridamole Er | None | 11 | $6,631 | $603 |
| Fludrocortisone Acetate | None | 170 | $5,164 | $30 |
| Depakote Er | None | 12 | $4,476 | $373 |
| Levetiracetam | None | 146 | $4,432 | $30 |
| Gabapentin | None | 239 | $4,022 | $17 |
| Propranolol | None | 149 | $3,758 | $25 |
| Dilantin | None | 21 | $3,242 | $154 |
| Duloxetine | None | 49 | $3,065 | $63 |
| Donepezil | None | 277 | $3,039 | $11 |
| Propranolol Hcl Er | None | 31 | $3,026 | $98 |
| Mirtazapine | None | 113 | $2,787 | $25 |
| Rivastigmine | None | 18 | $2,466 | $137 |
| Sumatriptan | None | 25 | $2,420 | $97 |
| Lamotrigine | None | 119 | $2,366 | $20 |
| Trospium Chloride | None | 20 | $2,232 | $112 |
| Pramipexole Dihydrochloride | None | 148 | $2,182 | $15 |
| Pyridostigmine | None | 20 | $2,125 | $106 |
| Escitalopram | None | 148 | $1,879 | $13 |
| Selegiline | None | 23 | $1,712 | $74 |
| Primidone | None | 113 | $1,690 | $15 |
| Chlorpromazine | None | 12 | $1,365 | $114 |
| Baclofen | None | 64 | $1,259 | $20 |
| Modafinil | None | 16 | $1,153 | $72 |
| Zonisamide | None | 52 | $1,081 | $21 |
| Quetiapine | None | 52 | $1,062 | $20 |
| Carbamazepine | None | 25 | $947 | $38 |
| Phenobarbital | None | 23 | $888 | $39 |
| Phenytoin Sodium Extended | None | 11 | $816 | $74 |
| Clozapine | None | 41 | $779 | $19 |
| Venlafaxine Hcl Er | None | 26 | $747 | $29 |
| Nortriptyline | None | 61 | $680 | $11 |
| Clopidogrel | None | 72 | $649 | $9 |
| Atorvastatin | None | 50 | $645 | $13 |
| Candesartan Cilexetil | None | 12 | $636 | $53 |
| Naratriptan | None | 12 | $605 | $50 |
| Divalproex | None | 29 | $492 | $17 |
| Topiramate | None | 37 | $451 | $12 |
| Diazepam | None | 65 | $436 | $7 |
| Levetiracetam Er | None | 11 | $396 | $36 |
| Indomethacin | None | 12 | $391 | $33 |
| Zolpidem | None | 37 | $389 | $11 |
| Clonazepam | None | 54 | $382 | $7 |
| Trazodone | None | 23 | $339 | $15 |
| Trihexyphenidyl | None | 20 | $305 | $15 |
| Lorazepam | None | 39 | $258 | $7 |
| Prednisone | None | 28 | $252 | $9 |
| Ibuprofen | None | 12 | $224 | $19 |
| Citalopram Hbr | None | 37 | $202 | $5 |
| Olanzapine | None | 16 | $161 | $10 |
| Buspirone | None | 16 | $126 | $8 |
| Tramadol | None | 19 | $114 | $6 |
| Sertraline | None | 20 | $76 | $4 |
| Sulfamethoxazole-Trimethoprim | None | 11 | $69 | $6 |
2017: 86 drugs
| Rasagiline Mesylate | None | 504 | $348,707 | $692 |
| Privigen | Immune globulin | 13 | $217,281 | $16,714 |
| Rytary | Parkinson's | 273 | $143,918 | $527 |
| Northera | None | 16 | $135,038 | $8,440 |
| Azilect | None | 145 | $120,933 | $834 |
| Nuplazid | Parkinson's psychosis | 43 | $93,459 | $2,173 |
| Tetrabenazine | None | 12 | $78,363 | $6,530 |
| Lyrica | None | 114 | $59,726 | $524 |
| Vimpat | None | 51 | $53,397 | $1,047 |
| Neupro | None | 55 | $43,729 | $795 |
| Carbidopa-Levodopa | None | 1,068 | $41,687 | $39 |
| Rivastigmine | None | 89 | $36,058 | $405 |
| Namenda Xr | None | 59 | $28,002 | $475 |
| Ampyra | None | 12 | $27,060 | $2,255 |
| Aptiom | None | 18 | $24,087 | $1,338 |
| Entacapone | None | 38 | $22,504 | $592 |
| Carbidopa-Levodopa-Entacapone | None | 41 | $21,409 | $522 |
| Mirapex Er | None | 22 | $16,051 | $730 |
| Memantine | None | 243 | $15,759 | $65 |
| Exelon | None | 22 | $14,505 | $659 |
| Myrbetriq | None | 25 | $13,915 | $557 |
| Vesicare | None | 32 | $12,256 | $383 |
| Amantadine | None | 130 | $11,766 | $91 |
| Midodrine | None | 136 | $11,359 | $84 |
| Onfi | None | 14 | $10,139 | $724 |
| Carbidopa-Levodopa Er | None | 187 | $9,554 | $51 |
| Pramipexole Er | None | 21 | $9,463 | $451 |
| Horizant | None | 11 | $8,444 | $768 |
| Aspirin-Dipyridamole Er | None | 12 | $6,424 | $535 |
| Fludrocortisone Acetate | None | 192 | $5,686 | $30 |
| Levetiracetam | None | 191 | $4,561 | $24 |
| Modafinil | None | 17 | $4,507 | $265 |
| Propranolol Hcl Er | None | 43 | $4,318 | $100 |
| Namzaric | None | 11 | $4,268 | $388 |
| Gabapentin | None | 255 | $3,895 | $15 |
| Depakote Er | None | 12 | $3,804 | $317 |
| Donepezil | None | 296 | $3,683 | $12 |
| Pramipexole Dihydrochloride | None | 167 | $3,590 | $21 |
| Duloxetine | None | 39 | $3,570 | $92 |
| Lamotrigine | None | 191 | $3,393 | $18 |
| Acetazolamide | None | 20 | $3,315 | $166 |
| Propranolol | None | 137 | $3,070 | $22 |
| Rivastigmine | None | 17 | $2,672 | $157 |
| Mirtazapine | None | 113 | $2,340 | $21 |
| Dilantin | None | 21 | $2,325 | $111 |
| Pyridostigmine | None | 24 | $2,156 | $90 |
| Selegiline | None | 27 | $2,147 | $80 |
| Carbamazepine | None | 22 | $2,066 | $94 |
| Primidone | None | 129 | $2,057 | $16 |
| Trospium Chloride | None | 16 | $1,922 | $120 |
| Divalproex | None | 77 | $1,794 | $23 |
| Lidocaine | None | 14 | $1,643 | $117 |
| Zonisamide | None | 67 | $1,232 | $18 |
| Baclofen | None | 84 | $1,090 | $13 |
| Clopidogrel | None | 73 | $1,024 | $14 |
| Pimozide | None | 13 | $1,004 | $77 |
| Phenytoin Sodium Extended | None | 26 | $994 | $38 |
| Levetiracetam Er | None | 26 | $967 | $37 |
| Nortriptyline | None | 89 | $964 | $11 |
| Clozapine | None | 46 | $938 | $20 |
| Ropinirole | None | 28 | $933 | $33 |
| Oxcarbazepine | None | 26 | $899 | $35 |
| Quetiapine | None | 69 | $804 | $12 |
| Amitriptyline | None | 25 | $772 | $31 |
| Escitalopram | None | 104 | $760 | $7 |
| Clonazepam | None | 80 | $635 | $8 |
| Venlafaxine Hcl Er | None | 58 | $634 | $11 |
| Phenobarbital | None | 22 | $610 | $28 |
| Topiramate | None | 64 | $546 | $9 |
| Oxybutynin Chloride | None | 19 | $476 | $25 |
| Lorazepam | None | 52 | $450 | $9 |
| Fluoxetine | None | 37 | $415 | $11 |
| Trihexyphenidyl | None | 26 | $399 | $15 |
| Oxybutynin Chloride Er | None | 14 | $381 | $27 |
| Zolpidem | None | 31 | $364 | $12 |
| Prednisone | None | 25 | $361 | $14 |
| Atorvastatin | None | 35 | $352 | $10 |
| Diazepam | None | 54 | $287 | $5 |
| Tizanidine | None | 22 | $282 | $13 |
| Cyclobenzaprine | None | 31 | $278 | $9 |
| Sumatriptan | None | 20 | $235 | $12 |
| Sertraline | None | 24 | $215 | $9 |
| Olanzapine | None | 17 | $208 | $12 |
| Citalopram Hbr | None | 61 | $167 | $3 |
| Trazodone | None | 16 | $143 | $9 |
| Famotidine | None | 12 | $49 | $4 |
2016: 86 drugs
| Azilect | None | 653 | $550,308 | $843 |
| Northera | None | 25 | $172,392 | $6,896 |
| Rytary | Parkinson's | 259 | $112,652 | $435 |
| Copaxone | None | 15 | $81,057 | $5,404 |
| Tetrabenazine | None | 11 | $60,240 | $5,476 |
| Lyrica | None | 99 | $46,198 | $467 |
| Neupro | None | 55 | $44,498 | $809 |
| Carbidopa-Levodopa | None | 1,092 | $32,257 | $30 |
| Namenda Xr | None | 54 | $29,209 | $541 |
| Ampyra | None | 13 | $26,397 | $2,031 |
| Rivastigmine | None | 59 | $20,268 | $344 |
| Entacapone | None | 41 | $19,988 | $488 |
| Exelon | None | 18 | $16,952 | $942 |
| Carbidopa-Levodopa-Entacapone | None | 22 | $15,998 | $727 |
| Amantadine | None | 174 | $14,245 | $82 |
| Vimpat | None | 20 | $13,357 | $668 |
| Memantine | None | 185 | $11,796 | $64 |
| Donepezil | None | 306 | $9,107 | $30 |
| Vesicare | None | 27 | $8,377 | $310 |
| Mirapex Er | None | 15 | $7,489 | $499 |
| Keppra | None | 15 | $6,866 | $458 |
| Pramipexole Er | None | 11 | $5,867 | $533 |
| Pramipexole Dihydrochloride | None | 199 | $5,730 | $29 |
| Modafinil | None | 26 | $5,245 | $202 |
| Carbidopa-Levodopa Er | None | 177 | $5,101 | $29 |
| Venlafaxine Hcl Er | None | 74 | $4,684 | $63 |
| Midodrine | None | 82 | $4,527 | $55 |
| Gabapentin | None | 266 | $4,206 | $16 |
| Fludrocortisone Acetate | None | 158 | $4,033 | $26 |
| Depakote Er | None | 12 | $3,604 | $300 |
| Propranolol Hcl Er | None | 56 | $3,504 | $63 |
| Levetiracetam | None | 147 | $3,206 | $22 |
| Pyridostigmine | None | 33 | $2,872 | $87 |
| Acetazolamide | None | 16 | $2,863 | $179 |
| Trimethobenzamide | None | 26 | $2,835 | $109 |
| Lidocaine | None | 13 | $2,824 | $217 |
| Duloxetine | None | 15 | $2,793 | $186 |
| Primidone | None | 131 | $2,260 | $17 |
| Carbamazepine | None | 24 | $2,211 | $92 |
| Rivastigmine | None | 20 | $2,109 | $105 |
| Lamotrigine | None | 152 | $2,052 | $13 |
| Selegiline | None | 26 | $1,978 | $76 |
| Ropinirole Er | None | 12 | $1,974 | $165 |
| Propranolol | None | 56 | $1,759 | $31 |
| Clopidogrel | None | 110 | $1,510 | $14 |
| Nortriptyline | None | 121 | $1,348 | $11 |
| Oxcarbazepine | None | 25 | $1,284 | $51 |
| Escitalopram | None | 116 | $1,226 | $11 |
| Baclofen | None | 78 | $1,119 | $14 |
| Zonisamide | None | 62 | $1,075 | $17 |
| Divalproex | None | 41 | $1,044 | $25 |
| Clozapine | None | 36 | $1,018 | $28 |
| Lorazepam | None | 67 | $850 | $13 |
| Trospium Chloride | None | 12 | $821 | $68 |
| Ropinirole | None | 29 | $795 | $27 |
| Clonazepam | None | 119 | $695 | $6 |
| Mirtazapine | None | 87 | $650 | $7 |
| Oxybutynin Chloride | None | 22 | $621 | $28 |
| Prazosin | None | 11 | $537 | $49 |
| Trihexyphenidyl | None | 41 | $529 | $13 |
| Quetiapine | None | 55 | $517 | $9 |
| Verapamil Er | None | 12 | $515 | $43 |
| Sumatriptan | None | 27 | $511 | $19 |
| Topiramate | None | 40 | $465 | $12 |
| Naratriptan | None | 11 | $424 | $39 |
| Prednisone | None | 47 | $409 | $9 |
| Pantoprazole | None | 22 | $378 | $17 |
| Tizanidine | None | 19 | $316 | $17 |
| Fluoxetine | None | 37 | $305 | $8 |
| Atorvastatin | None | 20 | $302 | $15 |
| Zolpidem | None | 31 | $302 | $10 |
| Rizatriptan | None | 13 | $259 | $20 |
| Diazepam | None | 61 | $247 | $4 |
| Levetiracetam Er | None | 11 | $236 | $21 |
| Indomethacin | None | 14 | $234 | $17 |
| Cyclobenzaprine | None | 50 | $225 | $5 |
| Polyethylene Glycol 3350 | None | 14 | $186 | $13 |
| Citalopram Hbr | None | 50 | $181 | $4 |
| Trazodone | None | 23 | $181 | $8 |
| Simvastatin | None | 25 | $154 | $6 |
| Ondansetron | None | 12 | $147 | $12 |
| Olanzapine | None | 12 | $107 | $9 |
| Sertraline | None | 17 | $92 | $5 |
| Alprazolam | None | 11 | $89 | $8 |
| Famotidine | None | 15 | $87 | $6 |
| Meloxicam | None | 15 | $29 | $2 |
2015: 76 drugs
| Azilect | None | 578 | $429,377 | $743 |
| Rytary | Parkinson's | 102 | $67,728 | $664 |
| Copaxone | None | 13 | $65,101 | $5,008 |
| Neupro | None | 68 | $50,647 | $745 |
| Lyrica | None | 85 | $36,687 | $432 |
| Namenda | None | 90 | $35,923 | $399 |
| Carbidopa-Levodopa | None | 914 | $32,632 | $36 |
| Carbidopa-Levodopa-Entacapone | None | 48 | $31,780 | $662 |
| Entacapone | None | 42 | $29,697 | $707 |
| Namenda Xr | None | 70 | $27,204 | $389 |
| Exelon | None | 44 | $22,267 | $506 |
| Vesicare | None | 49 | $15,943 | $325 |
| Amantadine | None | 154 | $13,452 | $87 |
| Donepezil | None | 317 | $12,022 | $38 |
| Keppra | None | 27 | $9,869 | $366 |
| Vimpat | None | 16 | $9,014 | $563 |
| Carbidopa-Levodopa Er | None | 182 | $8,445 | $46 |
| Mirapex Er | None | 15 | $6,764 | $451 |
| Pramipexole Dihydrochloride | None | 184 | $6,281 | $34 |
| Memantine | None | 69 | $5,494 | $80 |
| Gabapentin | None | 244 | $4,676 | $19 |
| Duloxetine | None | 22 | $4,567 | $208 |
| Midodrine | None | 57 | $3,847 | $67 |
| Levetiracetam | None | 163 | $3,119 | $19 |
| Depakote Er | None | 11 | $3,090 | $281 |
| Modafinil | None | 12 | $3,055 | $255 |
| Fludrocortisone Acetate | None | 128 | $3,023 | $24 |
| Acetazolamide | None | 19 | $2,915 | $153 |
| Trimethobenzamide | None | 22 | $2,718 | $124 |
| Propranolol Hcl Er | None | 31 | $2,493 | $80 |
| Selegiline | None | 20 | $2,269 | $113 |
| Pyridostigmine | None | 23 | $2,266 | $99 |
| Ropinirole | None | 48 | $2,248 | $47 |
| Primidone | None | 88 | $1,927 | $22 |
| Lamotrigine | None | 190 | $1,873 | $10 |
| Clopidogrel | None | 140 | $1,437 | $10 |
| Propranolol | None | 54 | $1,386 | $26 |
| Baclofen | None | 101 | $1,274 | $13 |
| Carbamazepine | None | 22 | $1,221 | $55 |
| Nortriptyline | None | 99 | $1,217 | $12 |
| Clonazepam | None | 134 | $1,139 | $8 |
| Clozapine | None | 47 | $1,025 | $22 |
| Oxcarbazepine | None | 35 | $897 | $26 |
| Zolpidem | None | 32 | $767 | $24 |
| Ondansetron | None | 15 | $693 | $46 |
| Mirtazapine | None | 60 | $677 | $11 |
| Trihexyphenidyl | None | 44 | $611 | $14 |
| Phenytoin Sodium Extended | None | 15 | $584 | $39 |
| Escitalopram | None | 69 | $574 | $8 |
| Quetiapine | None | 69 | $556 | $8 |
| Venlafaxine Hcl Er | None | 31 | $533 | $17 |
| Pantoprazole | None | 33 | $528 | $16 |
| Zonisamide | None | 36 | $504 | $14 |
| Topiramate | None | 30 | $476 | $16 |
| Oxybutynin Chloride | None | 14 | $443 | $32 |
| Lorazepam | None | 65 | $409 | $6 |
| Divalproex | None | 20 | $408 | $20 |
| Cyclobenzaprine | None | 53 | $406 | $8 |
| Tizanidine | None | 22 | $404 | $18 |
| Oxybutynin Chloride Er | None | 11 | $338 | $31 |
| Butalb-Caff-Acetaminoph-Codein | None | 12 | $335 | $28 |
| Prednisone | None | 31 | $323 | $10 |
| Diazepam | None | 82 | $319 | $4 |
| Methylphenidate | None | 12 | $306 | $25 |
| Rizatriptan | None | 15 | $229 | $15 |
| Atorvastatin | None | 13 | $188 | $14 |
| Citalopram Hbr | None | 39 | $177 | $5 |
| Trazodone | None | 29 | $143 | $5 |
| Indomethacin | None | 14 | $139 | $10 |
| Simvastatin | None | 11 | $88 | $8 |
| Sertraline | None | 15 | $86 | $6 |
| Hydrochlorothiazide | None | 11 | $82 | $7 |
| Famotidine | None | 16 | $76 | $5 |
| Fluoxetine | None | 13 | $69 | $5 |
| Ranitidine | None | 11 | $55 | $5 |
| Meloxicam | None | 16 | $23 | $1 |
2014: 76 drugs
| Azilect | 605 | $411,454 | $680 |
| Namenda | 181 | $64,208 | $355 |
| Carbidopa-Levodopa-Entacapone | 91 | $51,023 | $561 |
| Entacapone | 68 | $40,163 | $591 |
| Carbidopa-Levodopa | 865 | $38,829 | $45 |
| Neupro | 58 | $35,523 | $612 |
| Lyrica | 74 | $27,438 | $371 |
| Exelon | 54 | $20,545 | $380 |
| Mirapex Er | 31 | $19,232 | $620 |
| Namenda Xr | 57 | $18,662 | $327 |
| Frova | 47 | $18,239 | $388 |
| Amantadine | 168 | $16,276 | $97 |
| Donepezil | 323 | $14,336 | $44 |
| Vesicare | 47 | $13,106 | $279 |
| Aggrenox | 32 | $11,011 | $344 |
| Keppra | 35 | $9,653 | $276 |
| Vimpat | 18 | $9,297 | $516 |
| Ropinirole | 47 | $8,771 | $187 |
| Pramipexole Dihydrochloride | 209 | $8,445 | $40 |
| Carbidopa-Levodopa Er | 197 | $7,702 | $39 |
| Modafinil | 21 | $7,663 | $365 |
| Duloxetine | 19 | $6,420 | $338 |
| Lidoderm | 18 | $6,120 | $340 |
| Lamictal Xr | 13 | $5,618 | $432 |
| Levetiracetam | 151 | $5,102 | $34 |
| Gabapentin | 252 | $4,923 | $20 |
| Midodrine | 48 | $4,520 | $94 |
| Lamotrigine | 209 | $3,389 | $16 |
| Depakote Er | 12 | $3,154 | $263 |
| Fludrocortisone Acetate | 113 | $2,994 | $26 |
| Zetia | 12 | $2,308 | $192 |
| Primidone | 114 | $2,305 | $20 |
| Selegiline | 11 | $1,826 | $166 |
| Propranolol Hcl Er | 28 | $1,751 | $63 |
| Diovan | 15 | $1,663 | $111 |
| Nortriptyline | 119 | $1,615 | $14 |
| Clopidogrel | 110 | $1,298 | $12 |
| Cyclobenzaprine | 52 | $1,235 | $24 |
| Mirtazapine | 49 | $1,194 | $24 |
| Baclofen | 80 | $1,188 | $15 |
| Clozapine | 24 | $991 | $41 |
| Quetiapine | 81 | $981 | $12 |
| Divalproex | 38 | $951 | $25 |
| Escitalopram | 50 | $854 | $17 |
| Topiramate | 31 | $848 | $27 |
| Lorazepam | 79 | $817 | $10 |
| Clonazepam | 121 | $785 | $6 |
| Propranolol | 65 | $763 | $12 |
| Oxybutynin Chloride | 19 | $739 | $39 |
| Sumatriptan | 18 | $561 | $31 |
| Pyridostigmine | 12 | $540 | $45 |
| Trihexyphenidyl | 36 | $525 | $15 |
| Risperidone | 24 | $487 | $20 |
| Carbamazepine | 22 | $481 | $22 |
| Zonisamide | 12 | $478 | $40 |
| Oxybutynin Chloride Er | 12 | $474 | $39 |
| Oxcarbazepine | 12 | $455 | $38 |
| Citalopram Hbr | 60 | $433 | $7 |
| Pantoprazole | 32 | $381 | $12 |
| Methylphenidate | 12 | $321 | $27 |
| Tizanidine | 18 | $314 | $17 |
| Venlafaxine Hcl Er | 12 | $303 | $25 |
| Amitriptyline | 20 | $288 | $14 |
| Prednisone | 30 | $259 | $9 |
| Simvastatin | 43 | $236 | $5 |
| Diazepam | 64 | $233 | $4 |
| Zolpidem | 31 | $210 | $7 |
| Indomethacin | 12 | $171 | $14 |
| Trazodone | 33 | $154 | $5 |
| Acyclovir | 12 | $138 | $11 |
| Fluoxetine | 18 | $118 | $7 |
| Famotidine | 14 | $85 | $6 |
| Losartan | 15 | $83 | $6 |
| Sertraline | 11 | $68 | $6 |
| Meloxicam | 12 | $47 | $4 |
| Hydrochlorothiazide | 11 | $22 | $2 |
2013: 73 drugs
| Azilect | 595 | $367,617 | $618 |
| Carbidopa-Levodopa-Entacapone | 124 | $63,507 | $512 |
| Namenda | 156 | $50,615 | $324 |
| Avonex | 11 | $46,631 | $4,239 |
| Carbidopa-Levodopa | 677 | $33,130 | $49 |
| Entacapone | 51 | $28,290 | $555 |
| Frova | 79 | $25,150 | $318 |
| Mirapex Er | 35 | $19,219 | $549 |
| Neupro | 52 | $18,957 | $365 |
| Exelon | 44 | $18,220 | $414 |
| Lyrica | 62 | $17,838 | $288 |
| Ampyra | 12 | $17,721 | $1,477 |
| Aggrenox | 53 | $14,113 | $266 |
| Amantadine | 131 | $12,294 | $94 |
| Stalevo 150 | 23 | $12,265 | $533 |
| Lodosyn | 14 | $10,821 | $773 |
| Pramipexole Dihydrochloride | 189 | $10,621 | $56 |
| Modafinil | 12 | $10,537 | $878 |
| Vesicare | 36 | $10,062 | $280 |
| Ropinirole | 62 | $8,960 | $145 |
| Gabapentin | 297 | $8,598 | $29 |
| Donepezil | 272 | $7,377 | $27 |
| Keppra | 24 | $6,868 | $286 |
| Cymbalta | 19 | $6,817 | $359 |
| Clopidogrel | 131 | $5,588 | $43 |
| Carbidopa-Levodopa Er | 134 | $4,958 | $37 |
| Aricept | 14 | $4,462 | $319 |
| Midodrine | 55 | $4,147 | $75 |
| Levetiracetam | 101 | $4,140 | $41 |
| Depakote Er | 12 | $2,970 | $248 |
| Escitalopram | 61 | $2,635 | $43 |
| Fludrocortisone Acetate | 71 | $2,322 | $33 |
| Olanzapine | 14 | $2,069 | $148 |
| Propranolol | 90 | $2,044 | $23 |
| Lamotrigine | 153 | $1,834 | $12 |
| Quetiapine | 86 | $1,731 | $20 |
| Galantamine Hbr | 12 | $1,509 | $126 |
| Nortriptyline | 109 | $1,505 | $14 |
| Primidone | 92 | $1,497 | $16 |
| Topiramate | 37 | $1,476 | $40 |
| Divalproex Sodium Er | 15 | $1,353 | $90 |
| Diovan | 12 | $1,183 | $99 |
| Clozapine | 12 | $1,110 | $92 |
| Risperidone | 45 | $984 | $22 |
| Sumatriptan | 20 | $924 | $46 |
| Mirtazapine | 54 | $906 | $17 |
| Pyridostigmine | 11 | $822 | $75 |
| Lorazepam | 47 | $704 | $15 |
| Citalopram Hbr | 88 | $674 | $8 |
| Zonisamide | 14 | $645 | $46 |
| Divalproex | 35 | $644 | $18 |
| Baclofen | 71 | $639 | $9 |
| Clonazepam | 98 | $625 | $6 |
| Cyclobenzaprine | 41 | $613 | $15 |
| Trihexyphenidyl | 38 | $570 | $15 |
| Venlafaxine Hcl Er | 12 | $391 | $33 |
| Pantoprazole | 22 | $365 | $17 |
| Tizanidine | 26 | $360 | $14 |
| Bupropion Xl | 12 | $352 | $29 |
| Simvastatin | 51 | $339 | $7 |
| Methylphenidate | 11 | $285 | $26 |
| Indomethacin | 12 | $214 | $18 |
| Acyclovir | 17 | $212 | $12 |
| Carbamazepine | 17 | $206 | $12 |
| Zolpidem | 27 | $175 | $6 |
| Losartan | 12 | $147 | $12 |
| Diazepam | 36 | $141 | $4 |
| Trazodone | 23 | $106 | $5 |
| Prednisone | 23 | $103 | $4 |
| Amitriptyline | 15 | $102 | $7 |
| Meloxicam | 13 | $82 | $6 |
| Tramadol | 11 | $67 | $6 |
| Hydrochlorothiazide | 15 | $42 | $3 |
Money from drug and device companies
$643 in 2025
| 2025 | 6 | 10 | None | $643 |
| 2024 | 2 | 2 | None | $130 |
| 2023 | 2 | 3 | None | $222 |
| 2022 | 2 | 2 | None | $181 |
| 2021 | 2 | 2 | None | $193 |
| 2020 | 4 | 6 | None | $421 |
| 2019 | 8 | 13 | $20 | $1,015 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vyalev | $234 | 3 payments
|
| MDD US Operations | None | $139 | 2 payments
|
| Rapid Medical | Tigertriever 17 Revascularization Device | $138 | 1 payment
|
| Supernus Pharmaceuticals | None | $70 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $32 | 1 payment
|
| Ucb | Rystiggo | $30 | 2 payments
|
See all 10 published payments
| Abbvie | Meals · 2025-12-15 | Vyalev | $30 |
| Abbvie | Meals · 2025-11-12 | Vyalev | $105 |
| Alexion Pharmaceuticals | Meals · 2025-10-29 | Ultomiris | $32 |
| Abbvie | Meals · 2025-08-06 | Vyalev | $100 |
| MDD US Operations | Meals · 2025-06-13 | None | $124 |
| MDD US Operations | Meals · 2025-06-10 | None | $16 |
| Ucb | Education · 2025-06-04 | Rystiggo | $15 |
| Supernus Pharmaceuticals | Meals · 2025-05-17 | None | $70 |
| Rapid Medical | Meals · 2025-03-11 | Tigertriever 17 Revascularization Device | $138 |
| Ucb | Education · 2025-02-06 | Rystiggo | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $130
| Amneal Pharmaceuticals | Crexont | $112 | 1 payment
|
| Abbvie | Duopa | $17 | 1 payment
|
2023: $222
| Acorda Therapeutics | Inbrija | $131 | 2 payments
|
| AbbVie | Duopa | $92 | 1 payment
|
2022: $181
| ACADIA Pharmaceuticals | Nuplazid | $110 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $70 | 1 payment
|
2021: $193
| AbbVie | Ubrelvy | $99 | 1 payment
|
| Biogen | Aduhelm | $94 | 1 payment
|
2020: $421
| Medtronic USA | Activa | $134 | 3 payments
|
| Kyowa Kirin | Nourianz | $124 | 1 payment
|
| Allergan | Ubrelvy | $102 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $61 | 1 payment
|
2019: $1,015
| Lilly USA | None | $206 | 4 payments
|
| Medtronic USA | Activa | $175 | 1 payment
|
| Acorda Therapeutics | Inbrija | $138 | 2 payments
|
| Teva Pharmaceuticals USA | Ajovy | $130 | 2 payments
|
| Sunovion Pharmaceuticals | None | $125 | 1 payment
|
| Abbott Laboratories | Infinity Dbs Pulse Generators | $115 | 1 payment
|
| Boston Scientific | General Dbs | $96 | 1 payment
|
| Ucb | Neupro | $30 | 1 payment
|
Professional record
- NPI
- 1477504926
- Licence
- CA A81482California A81482: Current · expires 2028-06-30
- Trained
- University of California, Davis School of Medicine, 2001 · 25 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 2350 W El Camino Real Fl 2, Mountain View, CA, 94040
- NPI first listed
- 2006-05-12
- NPI last updated
- 2019-05-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4053 Lone Tree Way Ste 101, Antioch, CA, 94531 · 323 N Prairie Ave, Inglewood, CA, 90301